BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma von Kulkarni Atul, Al-Hraishawi, Husam, Simhadri Srilatha, Hirshfield, Kim M, Chen, Suzie, Pine, Sharon, Jeyamohan Chandrika, Sokol Levi, Siraj, Ali, Teo Man Lung, White, Eileen, Rodriguez-Rodriguez, Lorna, Mehnert, Janice M, Ganesan Shridar

Volltext

Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies von Stein, Mark, Lin, Hongxia, Jeyamohan, Chandrika, Dvorzhinski, Dmitri, Gounder, Murugesan, Bray, Kevin, Eddy, Simantini, Goodin, Susan, White, Eileen, DiPaola, Robert S.

Volltext

Autophagic cell death with hydroxychloroquine in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer von George, Mridula Annette, Mayer, Tina M., Moore, Dirk, Chen, Chunxia, White, Eileen, DiPaola, Robert S., Jeyamohan, Chandrika, Stein, Mark N.

Volltext

A phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle... von Hahn, Noah M., Chang, Sam, Meng, Maxwell, Shore, Neal D., Konety, Badrinath R., Steinberg, Gary D., Gschwend, Juergen, Nishiyama, Hiroyuki, Palou, Joan, Taylor, John A, Lambert, Alexandre, Zhu, Li, Maeda, Toshiki, Raybold, Bradley, Fischer, Bruce S., Jeyamohan, Chandrika, Zardavas, Dimitrios, Witjes, Fred

Volltext

A Phase II Study of AT-101 to Overcome Bcl-2–Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer von Stein, Mark N, Hussain, Maha, Stadler, Walter M, Liu, Glenn, Tereshchenko, Irina V, Goodin, Susan, Jeyamohan, Chandrika, Kaufman, Howard L, Mehnert, Janice, DiPaola, Robert S

Volltext

BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAF V600E Mutant Melanoma von Kulkarni, Atul, Al-Hraishawi, Husam, Simhadri, Srilatha, Hirshfield, Kim M, Chen, Suzie, Pine, Sharon, Jeyamohan, Chandrika, Sokol, Levi, Ali, Siraj, Teo, Man Lung, White, Eileen, Rodriguez-Rodriguez, Lorna, Mehnert, Janice M, Ganesan, Shridar

Volltext

Sunitinib (SU) plus extended courses of irradiated allogeneic lymphocytes (IAL) for patients with metastatic renal cell carcinoma (RCC) von Stein, Mark N., Huzzy, Lien, Anand, Monica, Jeyamohan, Chandrika, Mayer, Tina M., DiPaola, Robert S., Gharibo, Mecide Meric, Strair, Roger

Volltext

A randomized phase II study of bicalutamide (BIC) followed by placebo or gamma secretase inhibitor RO4929097 (RO492) in men with rising PSA von Stein, Mark N., DiPaola, Robert S., Mayer, Tina M., Jeyamohan, Chandrika, Metzger, Dorinda, Anand, Monica, Ivy, S. Percy

Volltext

A phase II study of atorvastatin and celecoxib in patients with rising PSA following local therapy for prostate cancer (PC) von Goodin, Susan, Stein, Mark N., Shih, Weichung, Lu, Shou-En, Zheng, Xi, Anand, Monica, Jeyamohan, Chandrika, Mayer, Tina M., Somer, Robert A., Heath, Elisabeth, Conney, Allan, DiPaola, Robert S.

Volltext

TargetingTumor MetabolismWith 2-Deoxyglucose in Patients With Castrate-Resistant Prostate Cancer and Advanced Malignancies von Stein, Mark, Lin, Hongxia, Jeyamohan, Chandrika, Dvorzhinski, Dmitri, Gounder, Murugesan, Bray, Kevin, Eddy, Simantini, Goodin, Susan, White, Eileen, DiPaola, Robert S.

Volltext